Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;30(1):30-37.
doi: 10.1158/1055-9965.EPI-20-0846. Epub 2020 Oct 20.

Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study

Jacqueline M Mix  1   2 , Elizabeth A Van Dyne  1   3 , Mona Saraiya  4 , Benjamin D Hallowell  1 , Cheryll C Thomas  1
Affiliations

Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study

Jacqueline M Mix et al. Cancer Epidemiol Biomarkers Prev. 2021 Jan.

Abstract

Background: To date, the impact of the human papillomavirus (HPV) vaccine on invasive cervical cancers in the United States has not been documented due, in part, to the time needed for cancer to develop and to recent changes to cervical cancer screening guidelines and recommendations, which complicate data interpretation.

Methods: We examined incidence rates of cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) among women aged 15-29 years diagnosed during 1999-2017 using population-based cancer registry data covering 97.8% of the U.S.

Population: Trends were stratified by age and histology. The annual percent change in cervical cancer incidence per year was calculated using joinpoint regression.

Results: During 1999-2017, SCC rates decreased 12.7% per year among women aged 15-20 years, 5.5% among women aged 21-24 years, and 2.3% among women aged 25-29 years. The declines in SCC rates were largest among women aged 15-20 years during 2010-2017, with a decrease of 22.5% per year. Overall, AC rates decreased 4.1% per year among women aged 15-20 years, 3.6% per year among women aged 21-24 years, and 1.6% per year among women aged 25-29 years. AC rates declined the most among women aged 15-20 years during 2006-2017, decreasing 9.4% per year.

Conclusions: Since HPV vaccine introduction, both SCC and AC incidence rates declined among women aged 15-20 years, a group not typically screened for cervical cancer, which may suggest HPV vaccine impact.

Impact: Timely vaccination and improved screening and follow-up among recommended age groups could result in further reductions in invasive cervical cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest

Figures

Figure 1.
Figure 1.. Timeline of relevant recommendations and guidelines in the United States for cervical cancer testing, HPV vaccination, screening, and management.
Abbreviations: HPV = human papillomavirus, FDA = Food and Drug Administration, ACS = American Cancer Society, ACOG = American College of Obstetrics and Gynecology, USPSTF = United States Preventive Services Task Force. This timeline depicts relevant events in the type of testing (Pap/HPV), HPV vaccination, age and frequency of testing, and management of cervical cancers and precancers.
Figure 2.
Figure 2.. Cervical Cancer Observed and Predicted Incidence Trends among Women Aged 15–20 Years by Histology, United States, 1999–2017.
Data Sources: Center for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. Incidence data compiled from cancer registries that met data quality standards from 1999 to 2017, covering 97.8% of the US population. AC refers to adenocarcinomas defined by ICD-O-3 histology codes 8140–8575; SCC refers to squamous cell carcinomas defined by ICD-O-3 histology codes 8050–8084 and 8120–8131. Black triangles represent observed incidence rates of SCC; black solid lines are the SCC modelled trends; black dotted lines are the SCC predicted trends; gray squares represent observed incidence rates of AC; gray dotted lines are the AC modelled trends; gray dotted lines are the AC predicted trends. Predicted rates were estimated based on the trends in 1999 to 2008 continuing to 2017 (see methods section for further information on methodology).
Figure 3.
Figure 3.. Cervical Cancer Observed and Predicted Incidence Trends among Women Aged 21–24 Years by Histology, United States, 1999–2017.
Data Sources: Center for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. Incidence data compiled from cancer registries that met data quality standards from 1999 to 2017, covering 97.8% of the US population. AC refers to adenocarcinomas defined by ICD-O-3 histology codes 8140–8575; SCC refers to squamous cell carcinomas defined by ICD-O-3 histology codes 8050–8084 and 8120–8131. Black triangles represent observed incidence rates of SCC, black solid lines are the SCC modelled trends, black dotted lines are the SCC predicted trends; gray squares represent observed incidence rates of AC, gray dotted lines are the AC modelled trends, gray dotted lines are the AC predicted trends. Predicted rates were estimated based on the trends in 1999 to 2008 continuing to 2017 (see methods section for further information on methodology).
Figure 4.
Figure 4.. Cervical Cancer Observed and Predicted Incidence Trends among Women Aged 21–24 Years by Histology, United States, 1999–2017.
Data Sources: Center for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. Incidence data compiled from cancer registries that met data quality standards from 1999 to 2017, 97.8% of the US population. AC refers to adenocarcinomas defined by ICD-O-3 histology codes 8140–8575; SCC refers to squamous cell carcinomas defined by ICD-O-3 histology codes 8050–8084 and 8120–8131. Black triangles represent observed incidence rates of SCC, black solid lines are the SCC modelled trends, black dotted lines are the SCC predicted trends; gray squares represent observed incidence rates of AC, gray dotted lines are the AC modelled trends, gray dotted lines are the AC predicted trends. Predicted rates were estimated based on the trends in 1999 to 2008 continuing to 2017 (see methods section for further information on methodology).
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. 2016. October 17. United States Cancer Statistics: Data Visualizations. <https://gis.cdc.gov/Cancer/USCS/DataViz.html>. Accessed 2019 October 17.
    1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports 2007;56(Rr-2):1–24. - PubMed
    1. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute 2015;107(6):djv086. - PMC - PubMed
    1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and mortality weekly report 2019;68(32):698–702 doi 10.15585/mmwr.mm6832a3. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. 2008. January 8 2008 Adolescent Human Papillomavirus (HPV) Vaccination Coverage Report. <https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-repo...>. Accessed 2020 January 8.

Publication types

Substances